PYPD NASDAQ
PolyPid Ltd.
1W: -22.7%
1M: -12.9%
3M: -13.8%
YTD: -8.5%
1Y: +6.4%
3Y: -67.2%
5Y: -98.5%
$3.75
-0.23 (-5.78%)
Weekly Expected Move ±17.8%
$3
$3
$4
$5
$5
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Smart Money Score
No convergence signal
Key Statistics
Market Cap$38.2M
52W Range3.06-5.73
Volume135,917
Avg Volume203,237
Beta1.40
Dividend—
Analyst Ratings
Company Info
CEODikla Czaczkes Akselbrad
Employees75
SectorHealthcare
IndustryBiotechnology
IPO Date2020-06-26
Websitepolypid.com
18 Hasivim Street
Petah Tikva, HM 4959376
IL
Petah Tikva, HM 4959376
IL
972 7 4719 5700
About PolyPid Ltd.
PolyPid Ltd. is an advanced-stage biopharmaceutical company specializing in the development, manufacturing, and commercialization of therapeutic solutions. These solutions are based on its proprietary polymer-lipid encapsulation matrix (PLEX) platform, with the goal of addressing significant unmet medical needs. The company's leading product candidate, D-PLEX100, is currently undergoing Phase III clinical trials. It is being evaluated for its efficacy in preventing surgical site infections (SSIs) following both sternal (bone) and abdominal (soft tissue) procedures. Established in 2008, PolyPid Ltd. is headquartered in Petah Tikva, Israel.
Latest News
Azurity Announces Plans to Commercialize D-PLEX100 in the U.S. and Canada through Exclusive Partnership with PolyPid
PolyPid Announces Exclusive Partnership with Azurity Pharmaceuticals for the Commercialization of D-PLEX₁₀₀ in the U.S. and Canada
PolyPid Completes New Drug Application Submission to FDA for D-PLEX₁₀₀
PolyPid to Participate in the Craig-Hallum 23rd Annual Institutional Investor Conference
PolyPid Ltd. Q1 2026 Earnings Call Summary
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Barenholz Yechezkel | A-Award | 9,132 | $4.46 | 2026-07-15 |
| Stein Robert Benjami | A-Award | 9,132 | $4.46 | 2026-07-15 |
| Dror-Darwish Nir | A-Award | 9,132 | $4.46 | 2026-07-15 |
| BenAmram Joseph | A-Award | 9,132 | $4.46 | 2026-07-15 |
| Krinsky Itzhak | A-Award | 9,132 | $4.46 | 2026-07-15 |